Issued 2026-09-25 at $158.23 · now $158.23 (2026-09-25, +0.0% since)
Based on its own history, a month from the 2026-09-25 close, EMR has typically landed between $140.97 and $178.47 — a range of −10.9% to +12.8% from the issuance price $158.23.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
4,692 overlapping 1 month windows · 2008-01-02 – 2026-08-26 · basis climatology · forecast (batch). Base rate up 53.7% (90% CI 51.5–55.9%, ≈1,391 obs). Not a call on this stock — we have no evidence its odds differ.
The cone is anchored at the 2026-09-25 issuance close ($158.23) — the price the forecast resolves against on 2026-10-26, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where EMR has typically landed a month from the 2026-09-25 close of $158.23 — the range is history, not a prediction.
- now $158.23 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $159.9 (+1.1%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $151.4–$168.41
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $140.97–$178.47
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2020-02-21 | −47.2% | −47.2% | +0.0% |
| 2020-02-18 | −42.4% | −42.4% | +0.9% |
| 2020-02-20 | −38.8% | −42.9% | +0.1% |
| 3 best | |||
| 2020-03-23 | +36.8% | +0.0% | +36.8% |
| 2009-03-05 | +26.7% | −1.4% | +26.7% |
| 2020-05-07 | +26.7% | −6.1% | +26.7% |
4,692 overlapping windows · 2008-01-02 – 2026-09-25 · not cherry-picked
Fundamentals iCompany financials — revenue, earnings, margins — from the newest filings shown, each carried with its date.iAs-reported figures and standard ratios from FMP, as of 2026-07-25. Revenue, net income and free cash flow can toggle annual or quarterly; margin, ROE and debt-to-equity are shown by fiscal year. We report the figures and the trend — no target price and no over/under-valued call. More on /methodology.
Fair value — three views iIndependent reference estimates of worth (a cash-flow model, peer multiples, analyst targets), shown as separate views — not a single verdict.
iThree independent estimates of per-share value, each by a different method and each with its own assumptions: a discounted-cash-flow intrinsic value, a peer comparable (the median trailing P/E of 74 sector peers times this company's trailing EPS), and the analyst price-target consensus. They routinely disagree — that gap is the point. We show the three marks and the current price; we do not blend them into a single number or call the stock over- or under-valued. Marks as of the latest capture. More on /methodology.- DCF (intrinsic)$107.48
- Peer P/E × EPS · sector median 30.7× · n=74$132.73
- Analyst target · range $144.00–$185.00$168.00
- Current price · last close 2026-09-25$158.23
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~19 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Karsanbhai Surendralal Lanca | director | Sale | 9,650 @ $161.91 | $1.6M | −3.4% of holding | −7.8% | not yet — horizon still open | 271,743 | Form 4 · filed 1 day after the trade |
| 2026-08-06 | Train Michael H. | officer | Sale | 7,329 @ $158.99 | $1.2M | −3.0% of holding | −2.8% | not yet — horizon still open | 238,516 | Form 4 · filed 1 day after the trade |
| 2026-06-01 | Krishnan Ram R. | director | Sale | 11,500 @ $141.22 | $1.6M | −6.7% of holding | −0.1% | not yet — horizon still open | 159,639 | Form 4 · filed 1 day after the trade |
| 2026-03-10 | Karsanbhai Surendralal Lanca | director | Sale | 5,700 @ $142.32 | $811K | −2.0% of holding | +2.6% | −5.4% | 281,393 | Form 4 · filed 2 days after the trade |
| 2026-02-10 | LEVATICH MATTHEW S | director | Sale | 1,476 @ $162.16 | $239K | −5.7% of holding | −14.2% | −10.4% | 24,349 | Form 4 · filed 2 days after the trade |
| 2026-02-09 | Piazza Nicholas J. | officer | Sale | 6,703 @ $159.07 | $1.1M | −17.5% of holding | −9.9% | −8.4% | 31,664 | Form 4 · filed 2 days after the trade |
| 2026-02-05 | BLINN MARK A | director | Sale | 1,476 @ $152.79 | $226K | −16.3% of holding | −6.2% | −9.0% | 7,555 | Form 4 · filed 4 days after the trade |
| 2026-02-05 | BLINN MARK A | director | Sale | 1,400 @ $152.44 | $213K | −13.4% of holding | −6.2% | −9.0% | 9,031 | Form 4 · filed 4 days after the trade |
| 2025-12-03 | Karsanbhai Surendralal Lanca | director | Sale | 7,263 @ $133.00 | $966K | −3.6% of holding | +5.0% | −5.3% | 196,292 | Form 4 · filed 1 day after the trade |
| 2025-05-12 | Train Michael H. | officer | Sale | 28,305 @ $119.44 | $3.4M | −10.8% of holding | +3.2% | −7.8% | 232,669 | Form 4 · filed 1 day after the trade |
| 2025-05-08 | Karsanbhai Surendralal Lanca | director | Sale | 16,698 @ $113.33 | $1.9M | −9.2% of holding | +6.1% | −1.3% | 164,957 | Form 4 · filed 1 day after the trade |
| 2025-02-12 | LEVATICH MATTHEW S | director | Sale | 1,867 @ $125.05 | $233K | −7.1% of holding | −3.0% | +1.3% | 24,574 | Form 4 · filed 1 day after the trade |
| 2025-02-12 | BLINN MARK A | director | Sale | 20 @ $125.24 | $3K | −0.2% of holding | −3.0% | +1.3% | 9,180 | Form 4 · filed 2 days after the trade |
| 2025-02-10 | BLINN MARK A | director | Sale | 1,867 @ $125.71 | $235K | −16.9% of holding | −4.6% | −1.1% | 9,200 | Form 4 · filed 2 days after the trade |
| 2024-11-13 | Karsanbhai Surendralal Lanca | director | Sale | 52,409 @ $130.51 | $6.8M | −35.2% of holding | −0.7% | −7.2% | 96,675 | Form 4 · filed 2 days after the trade |
| 2024-11-06 | Train Michael H. | officer | Sale | 21,525 @ $125.96 | $2.7M | −7.6% of holding | +0.8% | −4.4% | 262,408 | Form 4 · filed 2 days after the trade |
| 2024-03-04 | Piazza Nicholas J. | officer | Sale | 2,200 @ $108.50 | $239K | −8.8% of holding | +2.0% | −14.4% | 22,754 | Form 4 · filed 1 day after the trade |
| 2024-02-15 | LEVATICH MATTHEW S | director | Sale | 1,933 @ $105.58 | $204K | −7.2% of holding | +2.6% | −12.6% | 24,965 | Form 4 · filed 1 day after the trade |
| 2024-02-14 | Karsanbhai Surendralal Lanca | director | Sale | 2,344 @ $106.02 | $249K | −1.7% of holding | +2.0% | −12.5% | 138,750 | Form 4 · filed 2 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
231 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-03 | Piazza Nicholas J. | officer | Withheld for tax | 1,453 | 30,316 | Form 4 |
| 2026-08-03 | Newstead Jennifer | director | Award / grant | 622 | 622 | Form 4 |
| 2026-08-03 | Newstead Jennifer | director | Award / grant | 622 | 622 | Form 4 |
| 2026-04-06 | Train Michael H. | officer | Withheld for tax | 5,286 | 245,711 | Form 4 |
| 2026-03-09 | Krishnan Ram R. | director | Gift | 6,680 | 53,366 | Form 4 |
| 2026-03-09 | Krishnan Ram R. | director | Gift | 6,680 | 171,139 | Form 4 |
| 2026-03-09 | Krishnan Ram R. | director | Gift | 6,680 | 53,366 | Form 4 |
| 2026-03-09 | Krishnan Ram R. | director | Gift | 6,680 | 171,139 | Form 4 |
| 2026-02-09 | Krishnan Ram R. | director | Withheld for tax | 5,319 | 60,046 | Form 4 |
| 2026-02-05 | Karsanbhai Surendralal Lanca | director | Gift | 5,578 | 287,093 | Form 4 |
| 2026-02-05 | Karsanbhai Surendralal Lanca | director | Gift | 5,578 | 183,172 | Form 4 |
| 2026-02-05 | Karsanbhai Surendralal Lanca | director | Gift | 5,578 | 287,093 | Form 4 |
| 2026-02-05 | Karsanbhai Surendralal Lanca | director | Gift | 5,578 | 183,172 | Form 4 |
| 2026-02-03 | Lee Lori M | director | Award / grant | 1,251 | 15,113 | Form 4 |
| 2026-02-03 | BLINN MARK A | director | Award / grant | 1,251 | 10,431 | Form 4 |
| 2026-02-03 | BOLTEN JOSHUA B. | director | Award / grant | 1,251 | 31,294 | Form 4 |
| 2026-02-03 | FLACH GLORIA A | director | Award / grant | 1,251 | 20,249 | Form 4 |
| 2026-02-03 | Turley James S | director | Award / grant | 1,251 | 27,458 | Form 4 |
| 2026-02-03 | LEVATICH MATTHEW S | director | Award / grant | 1,251 | 25,825 | Form 4 |
| 2026-02-03 | BOLTEN JOSHUA B. | director | Award / grant | 1,251 | 31,294 | Form 4 |
| 2026-02-03 | Craighead Martin S | director | Award / grant | 1,251 | 14,867 | Form 4 |
| 2026-02-03 | McKelvey James Morgan Jr. | director | Award / grant | 1,251 | 16,013 | Form 4 |
| 2026-02-03 | BUTLER CALVIN JR | director | Award / grant | 1,251 | 3,489 | Form 4 |
| 2026-02-03 | McKelvey James Morgan Jr. | director | Award / grant | 1,251 | 16,013 | Form 4 |
| 2026-02-03 | BLINN MARK A | director | Award / grant | 1,251 | 10,431 | Form 4 |
| 2026-02-03 | BUTLER CALVIN JR | director | Award / grant | 1,251 | 3,489 | Form 4 |
| 2026-02-03 | FLACH GLORIA A | director | Award / grant | 1,251 | 20,249 | Form 4 |
| 2026-02-03 | Craighead Martin S | director | Award / grant | 1,251 | 14,867 | Form 4 |
| 2026-02-03 | Turley James S | director | Award / grant | 1,251 | 27,458 | Form 4 |
| 2026-02-03 | LEVATICH MATTHEW S | director | Award / grant | 1,251 | 25,825 | Form 4 |
| 2026-02-03 | Lee Lori M | director | Award / grant | 1,251 | 15,113 | Form 4 |
| 2026-02-02 | Karsanbhai Surendralal Lanca | director | Withheld for tax | 4,422 | 188,750 | Form 4 |
| 2026-01-02 | Tang Michael | officer | Withheld for tax | 4,571 | 31,439 | Form 4 |
| 2026-01-02 | Tang Michael | officer | Withheld for tax | 2,154 | 29,285 | Form 4 |
| 2025-12-15 | Karsanbhai Surendralal Lanca | director | Gift | 3,120 | 281,515 | Form 4 |
| 2025-12-15 | Karsanbhai Surendralal Lanca | director | Gift | 3,120 | 193,172 | Form 4 |
| 2025-12-15 | Karsanbhai Surendralal Lanca | director | Gift | 3,120 | 193,172 | Form 4 |
| 2025-12-15 | Karsanbhai Surendralal Lanca | director | Gift | 3,120 | 281,515 | Form 4 |
| 2025-12-10 | Krishnan Ram R. | director | Gift | 39,492 | 164,459 | Form 4 |
| 2025-12-10 | Krishnan Ram R. | director | Gift | 39,492 | 65,365 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures iStock trades disclosed by members of Congress for this company, by the date they were filed.iDisclosures shown as facts. A purchase “cluster” (≥2 members of Congress filing a buy within 90 days) has historically preceded modestly higher forward returns — and it persisted out-of-sample, though it roughly halved after 2021 (see below). A descriptive historical tendency, not a signal to trade and not used in our forecast. See /methodology.
As of 2026-09-25 · point-in-time by filed date
A cluster = ≥2 members of Congress filing a purchase within 90 days. The historical tilt persisted after 2021 but roughly halved (+45 → +32 bp/mo forward 1-month vs the S&P 500 weekly-grid baseline). Descriptive historical tendency — not a signal to trade, and not used in our forecast (audition-log 2026-07-27, recomputed 2026-09-08).
| Member | Chamber | Type | Filed | Traded | Size |
|---|---|---|---|---|---|
| Alan Armstrong | Senate | purchase | 2026-07-21 | 2026-03-27 | $1–15K |
| Ro Khanna | House | purchase | 2026-07-06 | 2026-06-16 | $1–15K |
| Ro Khanna | House | sale | 2026-06-09 | 2026-05-15 | $1–15K |
| Ro Khanna | House | purchase | 2026-06-09 | 2026-05-01 | $15–50K |
| Ro Khanna | House | purchase | 2026-06-09 | 2026-05-27 | $1–15K |
| Ro Khanna | House | purchase | 2026-05-11 | 2026-04-13 | $1–15K |
| Ro Khanna | House | purchase | 2026-05-11 | 2026-04-24 | $1–15K |
| Ro Khanna | House | sale | 2026-04-07 | 2026-03-30 | $1–15K |
| Ro Khanna | House | purchase | 2026-02-06 | 2026-01-23 | $1–15K |
| Ro Khanna | House | sale | 2026-02-06 | 2026-01-29 | $15–50K |
| Richard Dean Dr Mccormick | House | purchase | 2025-12-09 | 2025-11-05 | $1–15K |
| Valerie Hoyle | House | sale | 2025-10-10 | 2025-09-23 | $1–15K |
| Richard Dean Dr Mccormick | House | purchase | 2025-09-17 | 2023-03-15 | $1–15K |
| Valerie Hoyle | House | purchase | 2025-09-12 | 2025-07-14 | $1–15K |
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.